1. Visterra, Inc. (32 from 37 patents)

2. Massachusetts Institute of Technology (27 from 8,393 patents)

3. Momenta Pharmaceuticals, Inc. (24 from 116 patents)

4. Other (1 from 832,880 patents)

5. University of California (1 from 15,515 patents)

6. The General Hospital Corporation (1 from 2,893 patents)

7. University of Massachusetts (1 from 1,556 patents)

8. The Charles Stark Draper Laboratory, Inc. (1 from 1,068 patents)

9. Momenta Pharmacueticals, Inc. (1 from 1 patent)

10. Nishla Keiser (0 patent)

11. Ram Sasisekharan (0 patent)

12. Ganesh Venkataraman (0 patent)

13. Rahul Raman (0 patent)

14. Zachary Shriver (0 patent)

1. 12415865 - Antibody molecules to C5AR1 and uses thereof

2. 12338291 - Humanized antibody molecules to CD138 and uses thereof

3. 12297249 - Interleukin-2 agents and uses thereof

4. 12264203 - Humanized complement 5a receptor 1 antibodies and methods of use thereof

5. 12227587 - Humanized complement 5A receptor 1 antibodies and methods of use thereof

6. 12187807 - Antibody molecules to C5AR1 and uses thereof

7. 12098178 - Methods of using interleukin-2 agents

8. 12091451 - Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

9. 12084484 - Interleukin-2 agents and uses thereof

10. 12054539 - Antibody molecules to dengue virus and uses thereof

11. 12024552 - Ha binding agents

12. 11945868 - Antibody molecules to CD138 and uses thereof

13. 11912781 - Humanized complement 5A receptor 1 antibodies and methods of use thereof

14. 11890319 - Antibody molecule-drug conjugates and uses thereof

15. 11820979 - Binding polypeptides and methods of making the same